Frequently Asked Questions
23. What is the Parkinson’s Disease Biomarkers Program?
The Parkinson’s Disease Biomarkers Program, or PDBP, was developed by the National Institute of Neurological Disorders and Stroke to discover and validate biomarkers for Parkinson’s disease. Biomarkers are measurable characteristics that can reveal whether the disease is developing or progressing. Biomarkers could help doctors detect Parkinson’s disease before symptoms appear and improve diagnosis of the disorder.